Human whole-blood granulocyte aggregation in vitro

Granulocyte function is often studied using isolated cell suspensions. This approach requires time-consuming separation steps that might alter cell behavior. Prior methods also prevent interactions between different blood cell types. Researchers have long sought a more physiological way to assess granulocyte activation. Existing techniques may not reflect real-world conditions accurately. The need for a faster and more reliable method remains unmet. Whole-blood assays could provide a more natural setting for cell aggregation studies. This gap motivated the development of a new in vitro technique.

The goal was to create a whole-blood granulocyte aggregation assay that avoids cell separation. The method aims to preserve natural cell interactions and physiological conditions. Researchers wanted to quantify aggregation without isolating granulocytes first. They also sought to assess reproducibility and clinical relevance. The assay needed to be rapid and suitable for drug testing. The study focused on chemotactic responses and disease states. The approach was designed for both basic and applied research. This method could improve the study of cell activation in various conditions.

The method uses whole blood samples without prior cell separation. A chemotactic stimulus is added to induce aggregation. Formaldehyde fixation prevents cell dissociation after incubation. Chemical lysis removes erythrocytes from the sample. An electronic cell-sizing device counts single cells and aggregates. The process allows rapid quantification of granulocyte aggregation. The method avoids the need for centrifugation or washing steps. It enables real-time assessment of cell interactions in whole blood.

The assay showed a rapid granulocyte aggregation response to a tripeptide stimulus. Single granulocyte counts decreased while doublets and triplets increased. Lymphocyte numbers remained unchanged during the process. Intra-assay variability was consistently below 5%. Aggregation was reversible and occurred within minutes of stimulus addition. The method detected elevated aggregability in post-myocardial infarction patients. Results suggest the assay is sensitive and reproducible. It provides a more physiological alternative to traditional methods.

The new assay avoids cell separation and preserves natural interactions. It enables rapid and reliable quantification of granulocyte aggregation. The method is suitable for studying drug effects and disease states. Aggregation patterns differ between healthy volunteers and MI patients. The technique offers improved physiological relevance compared to prior methods. It provides a simpler and faster alternative for in vitro studies. The results suggest clinical utility in assessing cell activation. This approach may enhance understanding of granulocyte function in disease.